NewAmsterdam Pharma Company N.V. (NAMSW) has a market capitalization of $2.69B and trades at $23.40. The 52-week range is 5.45-29.99.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -13.4, Earnings Per Share (EPS) of $-1.75, annual revenue of $22.5M.
The stock has a beta of 0.13, operates in the Healthcare sector.
